| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.10 (0%) | 🛒 Add to cart |
| 90 | $0.70 | $73.66 $63.13 (14%) | 🛒 Add to cart |
| 120 | $0.63 | $98.21 $76.16 (22%) | 🛒 Add to cart |
| 180 | $0.58 | $147.31 $104.22 (29%) | 🛒 Add to cart |
| 270 | $0.55 | $220.97 $147.31 (33%) | 🛒 Add to cart |
| 360 | $0.53
Best per pill | $294.63 $189.40 (36%) | 🛒 Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.40 | $42.09 (0%) | 🛒 Add to cart |
| 60 | $0.99 | $84.18 $59.13 (30%) | 🛒 Add to cart |
| 90 | $0.85 | $126.27 $76.16 (40%) | 🛒 Add to cart |
| 120 | $0.78 | $168.36 $93.20 (45%) | 🛒 Add to cart |
| 180 | $0.72 | $252.54 $129.27 (49%) | 🛒 Add to cart |
| 270 | $0.66 | $378.81 $179.38 (53%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $505.07 $232.49 (54%) | 🛒 Add to cart |
Synonyms
| |||
Celebrex: Targeted Relief for Osteoarthritis and Rheumatoid Arthritis
Celebrex (celecoxib) is a prescription medication classified as a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor. It is designed to manage pain and inflammation associated with conditions like osteoarthritis and rheumatoid arthritis by selectively targeting the cyclooxygenase-2 (COX-2) enzyme, thereby reducing prostaglandin production. This mechanism offers effective symptomatic relief while potentially minimizing certain gastrointestinal side effects common to traditional NSAIDs. It is crucial for patients to use this medication under strict medical supervision due to its associated cardiovascular and gastrointestinal risks.
Features
- Active ingredient: Celecoxib
- Drug class: Selective COX-2 inhibitor NSAID
- Available strengths: 50 mg, 100 mg, 200 mg, and 400 mg capsules
- Administration: Oral
- Prescription status: Rx-only
- Manufacturer: Pfizer Inc.
Benefits
- Provides effective relief from chronic pain associated with osteoarthritis and rheumatoid arthritis.
- Reduces inflammation and stiffness, improving joint mobility and function.
- Selective inhibition of COX-2 may result in a lower risk of gastrointestinal ulcers compared to non-selective NSAIDs.
- Convenient once or twice daily dosing supports consistent therapeutic levels.
- Helps enhance quality of life by enabling greater participation in daily activities.
Common use
Celebrex is commonly prescribed for the management of osteoarthritis (OA), rheumatoid arthritis (RA), and ankylosing spondylitis. It is also approved for the treatment of acute pain, such as that experienced during menstrual cycles (primary dysmenorrhea), and for the reduction of adenomatous colorectal polyps in familial adenomatous polyposis (FAP), as an adjunct to usual care. Its anti-inflammatory and analgesic properties make it suitable for conditions where inflammation is a key driver of pain.
Dosage and direction
The dosage of Celebrex should be individualized based on the condition being treated and the patient’s response. For osteoarthritis, the recommended dose is 200 mg per day, administered as a single dose or divided as 100 mg twice daily. For rheumatoid arthritis, the dose is 100 mg to 200 mg twice daily. For acute pain or primary dysmenorrhea, the initial dose is 400 mg, followed by an additional 200 mg if needed on the first day, and 200 mg twice daily as required on subsequent days. For familial adenomatous polyposis, the recommended dose is 400 mg twice daily with food. Celebrex should be taken with a full glass of water, and may be taken with or without food. Do not crush, chew, or break the capsule.
Precautions
Patients should be aware that Celebrex may increase the risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may increase with duration of use and in patients with cardiovascular disease or risk factors. Celebrex is also associated with an increased risk of serious gastrointestinal adverse events, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Use with caution in patients with fluid retention, hypertension, or heart failure. Periodic monitoring of blood pressure, renal function, and hemoglobin is recommended during long-term therapy.
Contraindications
Celebrex is contraindicated in patients with known hypersensitivity to celecoxib, any components of the drug product, or other NSAIDs. It should not be used in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients. Celebrex is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. It is also contraindicated in patients with a history of gastrointestinal bleeding or active peptic ulcer disease.
Possible side effect
Common side effects may include headache, abdominal pain, dyspepsia, diarrhea, nausea, flatulence, and peripheral edema. Serious side effects can include cardiovascular thrombotic events, gastrointestinal bleeding, ulceration, and perforation, hepatotoxicity, hypertension, heart failure, renal injury, anaphylactic reactions, serious skin reactions, and hematologic toxicity. Patients should seek immediate medical attention if they experience signs of symptoms of these serious adverse events, such as chest pain, shortness of breath, weakness, slurred speech, black or bloody stools, vomiting blood, skin rash, or unexplained weight gain or swelling.
Drug interaction
Celebrex may interact with other medications, including anticoagulants like warfarin, leading to an increased risk of bleeding. Concurrent use with aspirin or other NSAIDs may increase the risk of gastrointestinal adverse events. Celebrex can reduce the antihypertensive effect of ACE inhibitors, angiotensin II receptor blockers, and beta-blockers. It may increase the plasma concentration of lithium and methotrexate, necessitating monitoring. Use with fluconazole may increase celecoxib plasma concentrations due to inhibition of CYP2C9. Concomitant use with corticosteroids or selective serotonin reuptake inhibitors (SSRIs) may increase the risk of gastrointestinal bleeding.
Missed dose
If a dose of Celebrex is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule resumed. Do not double the dose to make up for a missed one. Consistency in dosing helps maintain stable drug levels for effective symptom management.
Overdose
In case of overdose, symptoms may include lethargy, drowsiness, nausea, vomiting, epigastric pain, gastrointestinal bleeding, hypertension, acute renal failure, respiratory depression, coma, or anaphylaxis. There is no specific antidote for Celebrex overdose. Management should involve supportive and symptomatic care, including monitoring of vital signs and gastrointestinal function. Consider gastric lavage or administration of activated charcoal if presented soon after ingestion. Hemodialysis is not likely to be effective due to high protein binding.
Storage
Store Celebrex capsules at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container, tightly closed, and out of reach of children and pets. Protect from light and moisture. Do not use Celebrex beyond the expiration date printed on the packaging. Proper disposal of unused medication should be in accordance with local regulations, ideally through a medicine take-back program.
Disclaimer
This information is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Individual responses to medication may vary, and only a healthcare professional can determine the appropriate treatment based on a patient’s specific health status and history.
Reviews
Clinical studies and patient reports indicate that Celebrex is effective in reducing pain and improving function in many individuals with osteoarthritis and rheumatoid arthritis. Patients often note significant improvement in joint mobility and a reduction in daily discomfort. However, experiences vary, and some users report side effects such as digestive issues or increased blood pressure. It is essential to discuss both the potential benefits and risks with a healthcare provider to determine if Celebrex is a suitable option for your treatment plan. Long-term user satisfaction often correlates with appropriate patient selection, dosing, and ongoing monitoring.
